LY3298176, a novel long-actingGIP/GLP-1 coagonist, shows enhanced activity on weight loss and energy utilization whilst maintaining its efficacy for glycaemic control - Bokvist, K; Brown, R; Coskun, T (Diabetologia, 2017)
et al.